Skip to content

PeerfordResearch intelligence

Countries
Institutions
Researchers
Fields
Rankings
Compare
Commons

Search institutions, scholars, countries and publications

Countries
Institutions
Researchers
Fields
Rankings
Compare

CommonsWhere researchers talk about their work

Search institutions, scholars, countries and publications

Every figure here is counted by Peerford from the works themselves, the same way for every institution.

Browse

Countries
Institutions
Researchers
Fields
Rankings
Commons, for researchers

About

How Peerford counts
Compare institutions
Privacy
Terms of use

Contact

hello@peerford.com
https://wa.me/peerford · WhatsApp

Language

English
FrançaisFrench
PortuguêsPortuguese
العربيةArabic

Theme

SystemLightDark

Rachael Pius Ebuh · Peerford

University of Ibadan / Scholars

RE

Rachael Pius Ebuh

University of Ibadan

Publishing since 2024, latest 2025

Cancer Research
Applied Microbiology and Biotechnology
Genetics
Molecular Biology
Pathology and Forensic Medicine

Their record on OpenAlex
Download CV:PDF Word
Who they write with Where their co-authors are Every publication
Is this you? Sign in to edit your profile

Publications: 22024–2025
Citations: 8to those papers
h-index: 2i10-index 0
Field-weighted impact: 1.941.00 is the world average
World top 10%: 50%1 of 2 scored papers
Open access: 50%1 papers free to read

By year

Papers, and the citations to them

Publications, left axisCitations to that year’s papers, right axis2026 still in progress

Citations received each year

Peerford

To all their work, old papers included. Google Scholar also counts citations from theses, books and web pages, so its line runs higher.

What they work on

From the classification of each paper

Subfields

Cancer Research2100%
Applied Microbiology and Biotechnology150%

Publications

2 in all

Newest Most cited Oldest Title

Search their publications by title

In silico repurposing of FDA-approved drugs as multi-target inhibitors of glioblastoma
2025Scientific AfricanJournalOpen access5 citations10.1016/j.sciaf.2025.e02582
In silico discovery of potential androgen receptor and cytochrome P450 17A1 inhibitors from Camellia sinensis for prostate cancer treatment
2024Next research.

Genetics150%

Molecular Biology150%

Pathology and Forensic Medicine150%

Health Sciences
Life Sciences

Topics most written on

ATP Synthase and ATPases Research1
Cancer, Hypoxia, and Metabolism1
Cancer, Lipids, and Metabolism1
Glioma Diagnosis and Treatment1
Tannin, Tannase and Anticancer Activities1
Tea Polyphenols and Effects1

Who they write with

Their most frequent co-authors, and the papers those co-authors share

Where they publish

Next research.1
Scientific African1

How it can be read

50% free to read

Gold 1 · 50%In an open-access journal
Closed 1 · 50%Behind a paywall

Development goals addressed

From each paper’s title and abstract

3Good health and well-being1

Most cited

In silico repurposing of FDA-approved drugs as multi-target inhibitors of glioblastoma
Scientific African
20255 citationsWorld top 10%Open access · Gold
In silico discovery of potential androgen receptor and cytochrome P450 17A1 inhibitors from Camellia sinensis for prostate cancer treatment
Next research.3
20243 citations

Journal

3 citations

10.1016/j.nexres.2024.100068